Home > Research > Publications & Outputs > Functionalization of additive-manufactured Ti6A...

Electronic data

  • Manuscript_FINAL_29_07

    Rights statement: This is the author’s version of a work that was accepted for publication in Materials Chemistry and Physics. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Materials Chemistry and Physics, 273, 2021 DOI: 10.1016/j.matchemphys.2021.125099

    Accepted author manuscript, 4.33 MB, PDF document

    Available under license: CC BY-NC-ND: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

Links

Text available via DOI:

View graph of relations

Functionalization of additive-manufactured Ti6Al4V scaffolds with poly(allylamine hydrochloride)/poly(styrene sulfonate) bilayer microcapsule system containing dexamethasone

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Functionalization of additive-manufactured Ti6Al4V scaffolds with poly(allylamine hydrochloride)/poly(styrene sulfonate) bilayer microcapsule system containing dexamethasone. / Chudinova, Ekaterina; Koptyug, A; Mukhortova, Yulia et al.
In: Materials Chemistry and Physics, Vol. 273, 125099, 15.11.2021.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Chudinova, E, Koptyug, A, Mukhortova, Y, Pryadko, A, Volkova, A, Ivanov, A, Plotnikov, E, Khan, Y, Epple, M, Sokolova, V, Prymak, O, Douglas, T, Surmenev, R & Surmeneva, M 2021, 'Functionalization of additive-manufactured Ti6Al4V scaffolds with poly(allylamine hydrochloride)/poly(styrene sulfonate) bilayer microcapsule system containing dexamethasone', Materials Chemistry and Physics, vol. 273, 125099. https://doi.org/10.1016/j.matchemphys.2021.125099

APA

Chudinova, E., Koptyug, A., Mukhortova, Y., Pryadko, A., Volkova, A., Ivanov, A., Plotnikov, E., Khan, Y., Epple, M., Sokolova, V., Prymak, O., Douglas, T., Surmenev, R., & Surmeneva, M. (2021). Functionalization of additive-manufactured Ti6Al4V scaffolds with poly(allylamine hydrochloride)/poly(styrene sulfonate) bilayer microcapsule system containing dexamethasone. Materials Chemistry and Physics, 273, Article 125099. https://doi.org/10.1016/j.matchemphys.2021.125099

Vancouver

Chudinova E, Koptyug A, Mukhortova Y, Pryadko A, Volkova A, Ivanov A et al. Functionalization of additive-manufactured Ti6Al4V scaffolds with poly(allylamine hydrochloride)/poly(styrene sulfonate) bilayer microcapsule system containing dexamethasone. Materials Chemistry and Physics. 2021 Nov 15;273:125099. Epub 2021 Aug 3. doi: 10.1016/j.matchemphys.2021.125099

Author

Chudinova, Ekaterina ; Koptyug, A ; Mukhortova, Yulia et al. / Functionalization of additive-manufactured Ti6Al4V scaffolds with poly(allylamine hydrochloride)/poly(styrene sulfonate) bilayer microcapsule system containing dexamethasone. In: Materials Chemistry and Physics. 2021 ; Vol. 273.

Bibtex

@article{8cc9ddac851c48ea97b170ec96552b14,
title = "Functionalization of additive-manufactured Ti6Al4V scaffolds with poly(allylamine hydrochloride)/poly(styrene sulfonate) bilayer microcapsule system containing dexamethasone",
abstract = "Porous titanium alloy Ti6Al4V scaffolds manufactured via electron beam melting (EBM{\textregistered}) reveal broad prospects for applications in bone tissue engineering. However, local inflammation and even implant failure may occur while placing an implant into the body. Thus, the application of drug carriers to the surface of a metallic implant can provide treatment at the inflammation site. In this study, we propose to use polyelectrolyte (PE) microcapsules formed by layer-by-layer (LbL) synthesis loaded with both porous calcium carbonate (CaCO3) microparticles and the anti-inflammatory drug dexamethasone (DEX) to functionalize implant surfaces and achieve controlled drug release. Scanning electron microscopy indicated that the CaCO3 microparticles coated with PE bilayers loaded with DEX had a spherical shape with a diameter of 2.3 ± 0.2 μm and that the entire scaffold surface was evenly coated with the microcapsules. UV spectroscopy showed that LbL synthesis allows the manufacturing of microcapsules with 40% DEX. According to high performance liquid chromatography (HPLC) analysis, 80% of the drug was released within 24 h from the capsules consisting of three bilayers of polystyrene sulfonate (PSS) and poly(allylamine)hydrochloride (PAH). The prepared scaffolds functionalized with CaCO3 microparticles loaded with DEX and coated with PE bilayers showed hydrophilic surface properties with a water contact angle below 5°. Mouse embryonic fibroblast cells were seeded on Ti6Al4V scaffolds with and without LbL surface modification. The surface modification with LbL PE microcapsules with CaCO3 core affected cell morphology in vitro. The results confirmed that DEX had no toxic effect and did not prevent cell adhesion and spreading, thus no cytotoxic effect was observed, which will be further studied in vivo.",
keywords = "Additive manufacturing, Ti6Al4V scaffolds, Surface modification, Calcium carbonate, Microparticles, Dexamethasone",
author = "Ekaterina Chudinova and A Koptyug and Yulia Mukhortova and Artyom Pryadko and Anastasiya Volkova and Alexey Ivanov and Evgenii Plotnikov and Yelena Khan and M Epple and Viktoriya Sokolova and Oleg Prymak and Timothy Douglas and R Surmenev and M Surmeneva",
note = "This is the author{\textquoteright}s version of a work that was accepted for publication in Materials Chemistry and Physics. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Materials Chemistry and Physics, 273, 2021 DOI: 10.1016/j.matchemphys.2021.125099",
year = "2021",
month = nov,
day = "15",
doi = "10.1016/j.matchemphys.2021.125099",
language = "English",
volume = "273",
journal = "Materials Chemistry and Physics",
issn = "0254-0584",
publisher = "Elsevier BV",

}

RIS

TY - JOUR

T1 - Functionalization of additive-manufactured Ti6Al4V scaffolds with poly(allylamine hydrochloride)/poly(styrene sulfonate) bilayer microcapsule system containing dexamethasone

AU - Chudinova, Ekaterina

AU - Koptyug, A

AU - Mukhortova, Yulia

AU - Pryadko, Artyom

AU - Volkova, Anastasiya

AU - Ivanov, Alexey

AU - Plotnikov, Evgenii

AU - Khan, Yelena

AU - Epple, M

AU - Sokolova, Viktoriya

AU - Prymak, Oleg

AU - Douglas, Timothy

AU - Surmenev, R

AU - Surmeneva, M

N1 - This is the author’s version of a work that was accepted for publication in Materials Chemistry and Physics. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Materials Chemistry and Physics, 273, 2021 DOI: 10.1016/j.matchemphys.2021.125099

PY - 2021/11/15

Y1 - 2021/11/15

N2 - Porous titanium alloy Ti6Al4V scaffolds manufactured via electron beam melting (EBM®) reveal broad prospects for applications in bone tissue engineering. However, local inflammation and even implant failure may occur while placing an implant into the body. Thus, the application of drug carriers to the surface of a metallic implant can provide treatment at the inflammation site. In this study, we propose to use polyelectrolyte (PE) microcapsules formed by layer-by-layer (LbL) synthesis loaded with both porous calcium carbonate (CaCO3) microparticles and the anti-inflammatory drug dexamethasone (DEX) to functionalize implant surfaces and achieve controlled drug release. Scanning electron microscopy indicated that the CaCO3 microparticles coated with PE bilayers loaded with DEX had a spherical shape with a diameter of 2.3 ± 0.2 μm and that the entire scaffold surface was evenly coated with the microcapsules. UV spectroscopy showed that LbL synthesis allows the manufacturing of microcapsules with 40% DEX. According to high performance liquid chromatography (HPLC) analysis, 80% of the drug was released within 24 h from the capsules consisting of three bilayers of polystyrene sulfonate (PSS) and poly(allylamine)hydrochloride (PAH). The prepared scaffolds functionalized with CaCO3 microparticles loaded with DEX and coated with PE bilayers showed hydrophilic surface properties with a water contact angle below 5°. Mouse embryonic fibroblast cells were seeded on Ti6Al4V scaffolds with and without LbL surface modification. The surface modification with LbL PE microcapsules with CaCO3 core affected cell morphology in vitro. The results confirmed that DEX had no toxic effect and did not prevent cell adhesion and spreading, thus no cytotoxic effect was observed, which will be further studied in vivo.

AB - Porous titanium alloy Ti6Al4V scaffolds manufactured via electron beam melting (EBM®) reveal broad prospects for applications in bone tissue engineering. However, local inflammation and even implant failure may occur while placing an implant into the body. Thus, the application of drug carriers to the surface of a metallic implant can provide treatment at the inflammation site. In this study, we propose to use polyelectrolyte (PE) microcapsules formed by layer-by-layer (LbL) synthesis loaded with both porous calcium carbonate (CaCO3) microparticles and the anti-inflammatory drug dexamethasone (DEX) to functionalize implant surfaces and achieve controlled drug release. Scanning electron microscopy indicated that the CaCO3 microparticles coated with PE bilayers loaded with DEX had a spherical shape with a diameter of 2.3 ± 0.2 μm and that the entire scaffold surface was evenly coated with the microcapsules. UV spectroscopy showed that LbL synthesis allows the manufacturing of microcapsules with 40% DEX. According to high performance liquid chromatography (HPLC) analysis, 80% of the drug was released within 24 h from the capsules consisting of three bilayers of polystyrene sulfonate (PSS) and poly(allylamine)hydrochloride (PAH). The prepared scaffolds functionalized with CaCO3 microparticles loaded with DEX and coated with PE bilayers showed hydrophilic surface properties with a water contact angle below 5°. Mouse embryonic fibroblast cells were seeded on Ti6Al4V scaffolds with and without LbL surface modification. The surface modification with LbL PE microcapsules with CaCO3 core affected cell morphology in vitro. The results confirmed that DEX had no toxic effect and did not prevent cell adhesion and spreading, thus no cytotoxic effect was observed, which will be further studied in vivo.

KW - Additive manufacturing

KW - Ti6Al4V scaffolds

KW - Surface modification

KW - Calcium carbonate

KW - Microparticles

KW - Dexamethasone

U2 - 10.1016/j.matchemphys.2021.125099

DO - 10.1016/j.matchemphys.2021.125099

M3 - Journal article

VL - 273

JO - Materials Chemistry and Physics

JF - Materials Chemistry and Physics

SN - 0254-0584

M1 - 125099

ER -